Innate Pharma (IPHYF) Short Interest Ratio & Short Volume $2.90 0.00 (0.00%) As of 01/21/2025 Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Innate Pharma Short Interest DataInnate Pharma (IPHYF) has a short interest of 500 shares. This marks a -94.05% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 1 shares to cover all short positions.Current Short Interest500 sharesPrevious Short Interest8,400 sharesChange Vs. Previous Month-94.05%Dollar Volume Sold Short$1,450.00Short Interest Ratio5.0 Days to CoverLast Record DateDecember 31, 2024Today's Trading Volume0 sharesAverage Trading Volume1 sharesToday's Volume Vs. Average0% Short Selling Innate Pharma? Sign up to receive the latest short interest report for Innate Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIPHYF Short Interest Over TimeIPHYF Days to Cover Over TimeIPHYF Percentage of Float Shorted Over Time Innate Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/2024500 shares $1,450.00 -94.1%N/A5 $2.90 12/15/20248,400 shares $24,360.00 +425.0%N/A21 $2.90 11/30/20241,600 shares $2,048.00 -61.9%N/A0 $1.28 11/15/20244,200 shares $5,376.00 -14.3%N/A42 $1.28 10/31/20244,900 shares $11,000.50 -17.0%N/A0 $2.25 10/15/20245,900 shares $13,245.50 -1.7%N/A0 $2.25 9/30/20246,000 shares $13,470.00 +22.5%N/A10 $2.25 9/15/20244,900 shares $11,270.00 No ChangeN/A0 $2.30 8/31/20244,900 shares $11,270.00 -21.0%N/A24.5 $2.30 8/15/20246,200 shares $13,020.00 -8.8%N/A12.4 $2.10 Get the Latest News and Ratings for IPHYF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/20246,800 shares $13,124.68 +23.6%N/A0 $1.93 7/15/20245,500 shares $10,615.55 No ChangeN/A55 $1.93 6/30/20245,500 shares $13,695.00 -30.4%N/A0 $2.49 6/15/20247,900 shares $19,671.00 +43.6%N/A7.2 $2.49 5/31/20245,500 shares $12,100.00 No ChangeN/A55 $2.20 5/15/20245,500 shares $12,100.00 -6.8%N/A2.5 $2.20 4/30/20245,900 shares $15,635.00 -1.7%N/A0 $2.65 4/15/20246,000 shares $15,900.00 +3.5%N/A60 $2.65 3/31/20245,800 shares $14,964.00 No ChangeN/A29 $2.58 3/15/20245,800 shares $14,152.00 +1.8%N/A58 $2.44 2/29/20245,700 shares $16,188.00 No ChangeN/A0 $2.84 2/15/20245,700 shares $16,188.00 -5.0%N/A0 $2.84 1/15/20244,800 shares $13,632.00 +108.7%N/A48 $2.84 12/31/20232,300 shares $6,532.00 -48.9%N/A4.5 $2.84 12/15/20234,500 shares $11,475.00 +650.0%N/A22.5 $2.55 11/30/2023600 shares $1,434.00 +500.0%N/A0 $2.39 11/15/2023100 shares $239.00 No ChangeN/A1 $2.39 10/15/20239,800 shares $22,625.26 +9,700.0%N/A19.6 $2.31 9/30/2023100 shares $300.00 No ChangeN/A0 $3.00 8/31/202311,600 shares $33,698.00 +11,500.0%N/A43.5 $2.91 8/15/2023100 shares $291.00 -75.0%N/A1 $2.91 7/31/2023400 shares $1,196.00 No ChangeN/A4 $2.99 7/15/2023400 shares $1,232.00 +33.3%N/A4 $3.08 6/30/2023300 shares $1,008.00 +200.0%N/A3 $3.36 6/15/2023100 shares $334.00 -80.0%N/A0.3 $3.34 5/31/2023500 shares $1,465.00 +400.0%N/A0 $2.93 5/15/2023100 shares $293.00 -75.0%N/A1 $2.93 4/30/2023400 shares $1,152.00 +100.0%N/A4 $2.88 4/15/2023200 shares $542.00 -97.8%N/A0 $2.71 3/31/20239,200 shares $24,932.00 -27.6%N/A92 $2.71Elon Musk’s FINAL Move (Ad)I call it "Elon's Final Move" because his new AI venture will dominate Tesla...Get all the details here >>> 3/15/202312,700 shares $39,497.00 +1,487.5%N/A63.5 $3.11 2/28/2023800 shares $2,344.00 +14.3%N/A8 $2.93 2/15/2023700 shares $2,408.00 -95.5%N/A0 $3.44 1/31/202315,700 shares $54,008.00 +15,600.0%N/A52.3 $3.44 1/15/2023100 shares $347.00 -97.1%N/A0.3 $3.47 12/30/20223,500 shares $11,445.00 -60.7%N/A0.7 $3.27 12/15/20228,900 shares $20,648.00 +8,800.0%N/A22.3 $2.32 11/30/2022100 shares $218.88 -90.9%N/A1 $2.19 11/15/20221,100 shares $2,519.00 -80.4%N/A1.1 $2.29 10/31/20225,600 shares $11,697.84 +30.2%N/A56 $2.09 10/15/20224,300 shares $8,901.00 +4,200.0%N/A2.3 $2.07 9/30/2022100 shares $193.00 -66.7%N/A1 $1.93 9/15/2022300 shares $780.00 -97.7%N/A1.5 $2.60 8/31/202212,800 shares $35,840.00 +236.8%N/A8.5 $2.80 8/15/20223,800 shares $10,564.00 +11.8%N/A12.7 $2.78 7/31/20223,400 shares $10,744.00 +6.3%N/A34 $3.16 7/15/20223,200 shares $8,640.00 -3.0%N/A32 $2.70 6/30/20223,300 shares $8,580.00 -15.4%N/A1.2 $2.60 6/15/20223,900 shares $10,803.00 -54.7%N/A39 $2.77 5/31/20228,600 shares $24,338.00 +34.4%N/A86 $2.83 5/15/20226,400 shares $18,112.00 -4.5%N/A32 $2.83 4/30/20226,700 shares $18,391.50 +8.1%N/A67 $2.75 4/15/20226,200 shares $18,910.00 +51.2%N/A12.4 $3.05 3/31/20224,100 shares $14,186.00 -93.9%N/A41 $3.46 3/15/202267,000 shares $241,870.00 -10.8%N/A0 $3.61 2/28/202275,100 shares $271,111.00 +1,004.4%N/A751 $3.61 2/15/20226,800 shares $25,228.00 -70.0%N/A5.7 $3.71 1/31/202222,700 shares $85,579.00 +57.6%N/A37.8 $3.77 1/15/202214,400 shares $62,640.00 +5.1%N/A0 $4.35 12/31/202113,700 shares $59,595.00 +407.4%N/A5.1 $4.35 12/15/20212,700 shares $13,743.00 -52.6%N/A1.4 $5.09 11/30/20215,700 shares $28,618.56 +1.8%N/A6.3 $5.02 11/15/20215,600 shares $28,000.00 -51.7%N/A3.1 $5.00 10/29/202111,600 shares $65,656.00 -6.5%N/A4.1 $5.66 10/15/202112,400 shares $73,160.00 +63.2%N/A6.5 $5.90 9/30/20217,600 shares $47,500.00 -26.2%N/A0.7 $6.25 9/15/202110,300 shares $58,504.00 -94.6%N/A0.7 $5.68 8/31/2021191,300 shares $679,115.00 -49.5%N/A956.5 $3.55 8/13/2021378,500 shares $1.22 million -0.1%N/A3785 $3.22 7/30/2021378,700 shares $1.19 million +0.2%N/A3787 $3.15 7/15/2021378,100 shares $1.23 million +0.0%N/A315.1 $3.25 6/30/2021378,000 shares $1.23 million No ChangeN/A315 $3.25 6/15/2021378,000 shares $1.34 million -0.5%N/A3780 $3.55 5/28/2021379,800 shares $1.44 million -10.3%N/A0 $3.80 5/14/2021423,400 shares $1.74 million +2.3%N/A4234 $4.11 4/30/2021414,000 shares $1.85 million +3.3%N/A828 $4.48 4/15/2021400,700 shares $1.80 million +1,627.2%N/A4007 $4.48 3/31/202123,200 shares $102,506.88 -94.2%N/A77.3 $4.42 3/15/2021401,900 shares $1.82 million 0.0%N/A4019 $4.53 2/26/2021402,000 shares $1.79 million -0.1%N/A1340 $4.46Elon Musk’s FINAL Move (Ad)I call it "Elon's Final Move" because his new AI venture will dominate Tesla...Get all the details here >>> 2/12/2021402,300 shares $1.94 million -0.7%N/A365.7 $4.81 1/29/2021405,200 shares $1.75 million No ChangeN/A4052 $4.33 1/15/2021405,500 shares $1.91 million 0.0%N/A1013.8 $4.72 12/31/2020405,200 shares $1.72 million -0.1%N/A368.4 $4.24 12/15/2020405,500 shares $1.77 million 0.0%N/A1013.8 $4.36 11/30/2020405,600 shares $2.21 million -0.4%N/A450.7 $5.45 11/15/2020407,100 shares $1.81 million No ChangeN/A1017.8 $4.45 10/30/2020407,100 shares $1.51 million +0.2%N/A508.9 $3.70 10/15/2020406,300 shares $1.66 million -0.1%N/A677.2 $4.08 9/30/2020406,600 shares $1.55 million -3.1%N/A4066 $3.80 9/15/2020419,700 shares $1.73 million +3.3%N/A182.5 $4.13 8/31/2020406,200 shares $2.62 million No ChangeN/A2031 $6.45 8/14/2020406,200 shares $2.62 million +0.2%N/A1354 $6.44 7/31/2020405,500 shares $2.56 million No ChangeN/A0 $6.33 7/15/2020405,500 shares $2.56 million No ChangeN/A4055 $6.33 6/30/2020405,500 shares $2.46 million +1,897.5%N/A2027.5 $6.06 6/15/202020,300 shares $128,905.00 +0.5%N/A40.6 $6.35 5/29/202020,200 shares $125,846.00 -95.0%N/A0 $6.23 5/15/2020405,200 shares $2.86 million No ChangeN/A193 $7.07 4/30/2020405,200 shares $2.66 million No ChangeN/A4052 $6.57 4/15/2020405,200 shares $2.24 million 0.0%N/A405.2 $5.53 3/31/2020405,300 shares $2.72 million -0.6%N/A579 $6.70 3/13/2020407,900 shares $2.00 million +0.6%N/A4079 $4.90 2/28/2020405,300 shares $2.97 million -4.8%N/A4053 $7.34 2/14/2020425,900 shares $3.05 million -1.2%N/A2129.5 $7.17 1/31/2020430,900 shares $3.23 million -9.0%N/A718.2 $7.50 IPHYF Short Interest - Frequently Asked Questions What is Innate Pharma's current short interest? Short interest is the volume of Innate Pharma shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 500 shares of IPHYF short. Learn More on Innate Pharma's current short interest. What is a good short interest ratio for Innate Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IPHYF shares currently have a short interest ratio of 5.0. Learn More on Innate Pharma's short interest ratio. Is Innate Pharma's short interest increasing or decreasing? Innate Pharma saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 500 shares, a decrease of 94.0% from the previous total of 8,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Innate Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Innate Pharma: Poseida Therapeutics, Inc. (3.67%), Anavex Life Sciences Corp. (25.70%), Relay Therapeutics, Inc. (8.93%), Sana Biotechnology, Inc. (30.31%), Immatics (8.02%), Replimune Group, Inc. (9.66%), Cullinan Therapeutics, Inc. (26.66%), LENZ Therapeutics, Inc. (11.31%), Autolus Therapeutics plc (3.24%), Tectonic Therapeutic (7.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Innate Pharma stock? Short selling IPHYF is an investing strategy that aims to generate trading profit from Innate Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innate Pharma? A short squeeze for Innate Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IPHYF, which in turn drives the price of the stock up even further. How often is Innate Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPHYF, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies Poseida Therapeutics Short Interest Anavex Life Sciences Short Interest Relay Therapeutics Short Interest Sana Biotechnology Short Interest Immatics Short Interest Replimune Group Short Interest Cullinan Therapeutics Short Interest LENZ Therapeutics Short Interest Autolus Therapeutics Short Interest Tectonic Therapeutic Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:IPHYF) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innate Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
